Changlong Li
Impact in
- Geriatrics and Gerontology top 2%
- Sirtuins and Resveratrol in Medicine
- Physiology top 5%
- Adipose Tissue and Metabolism
Papers in
-
- Epigenetics and DNA Methylation 8
- Natural product bioactivities and synthesis 6
- Cancer-related gene regulation 5
- RNA modifications and cancer 5
-
- Cancer-related molecular mechanisms research 9
- Co-authors
- Na Xie (3 shared papers)Lu Zhang (2 shared papers)Peter Huber (1 shared paper)Wei Gao (1 shared paper)Guobo Shen (1 shared paper)Xiaobo Zhou (1 shared paper)Bingwen Zou (1 shared paper)Canhua Huang (1 shared paper)
- Journals
- Biochemical and Biophysical Research Communications (4 papers)PLoS ONE (3 papers)BioMed Research International (2 papers)EXPERIMENTAL ANIMALS (2 papers)Aging (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Changlong Li
103 papers receiving 2.6k citations
Changlong Li's Hit Papers
Peers
Comparison fields: 5 of 141
- Geriatrics and Gerontology 153
- Physiology 100
- Cancer Research 275
- Biological Psychiatry 40
- Animal Science and Zoology 129
Countries citing papers authored by Changlong Li
This map shows the geographic impact of Changlong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changlong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changlong Li more than expected).
Fields of papers citing papers by Changlong Li
This network shows the impact of papers produced by Changlong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changlong Li. The network helps show where Changlong Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Changlong Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 112 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential Hit paper breakdown → | 2020 | 671 |
| 2 | MXene Functionalized, Highly Breathable and Sensitive Pressure Sensors with Multi‐Layered Porous Structure Hit paper breakdown → | 2023 | 189 |
| 3 | 2007 | 128 | |
| 4 | 2023 | 93 | |
| 5 | 2008 | 85 | |
| 6 | 2013 | 83 | |
| 7 | 2023 | 75 | |
| 8 | 2021 | 56 | |
| 9 | 2015 | 55 | |
| 10 | 2017 | 51 | |
| 11 | 2011 | 51 | |
| 12 | 2018 | 47 | |
| 13 | 2019 | 46 | |
| 14 | 2004 | 45 | |
| 15 | 2016 | 37 | |
| 16 | 2018 | 34 | |
| 17 | 2012 | 33 | |
| 18 | 2003 | 32 | |
| 19 | 2020 | 31 | |
| 20 | 2003 | 30 |
About Changlong Li
Changlong Li is a scholar working on Molecular Biology, Cancer Research, Oncology, Surgery and Genetics, having authored 112 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), Epigenetics and DNA Methylation (8 papers), Genetic diversity and population structure (6 papers), Natural product bioactivities and synthesis (6 papers), Helicobacter pylori-related gastroenterology studies (6 papers), Cancer-related Molecular Pathways (5 papers), Cancer-related gene regulation (5 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Geriatrics and Gerontology (153 citations), Physiology (100 citations), Cancer Research (275 citations), Biological Psychiatry (40 citations) and Animal Science and Zoology (129 citations). Changlong Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Na Xie, Lu Zhang, Peter Huber, Wei Gao, Guobo Shen, Xiaobo Zhou, Bingwen Zou, Canhua Huang, Xianhong Zheng and Liu Yan-wen. Their work appears in journals such as Biochemical and Biophysical Research Communications, PLoS ONE, BioMed Research International, EXPERIMENTAL ANIMALS and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.